You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Details for Patent: 11,844,804


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,844,804
Title:Administration of testosterone compositions
Abstract:The present invention provides compositions and methods for treating a subject in need of treatment with testosterone, including introducing testosterone into the subject subcutaneously, intradermally, or intramuscularly, from a needle assisted jet injection device.
Inventor(s):Paul K. WOTTON, Hermanus L. Jooste, Kaushik J. Dave, Jonathan Jaffe
Assignee:Antares Pharma Inc
Application Number:US17/157,310
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 11,844,804

Introduction to U.S. Patents

When analyzing a U.S. patent, it is crucial to understand the various components that define its scope and claims. This article will delve into the specifics of United States Patent 11,844,804, using general principles of patent law and the structure of a typical U.S. patent.

Structure of a U.S. Patent

A U.S. patent document is divided into several key sections, each providing essential information about the invention.

Bibliographic Data

The front page of the patent includes bibliographic data identified by INID codes. These codes provide details such as the document number, application number, date of application, date of patent, IPC classification, and national classification[4].

Abstract

The abstract section offers a brief, non-technical description of the invention, giving a general overview of what the patent covers[4].

Specification

This section is a detailed written description of the invention. It includes discussions of related prior art, descriptions of the drawings, how the invention solves a specific technical problem, and the preferred embodiment of the invention. The specification must be detailed enough for anyone with ordinary skill in the same technical field to understand and replicate the invention[4].

Drawings

The drawings section contains illustrations of the technical details of the invention. These drawings are not required for all types of inventions, such as those related to processes or methods[4].

Claims

The claims section is critical as it defines the scope of protection for the patent. Claims are paragraphs located at the end of the specification and are preceded by phrases such as "I claim" or "What is claimed." These claims legally define the boundaries of the invention, similar to how a property deed defines physical boundaries[4].

Analyzing the Claims of United States Patent 11,844,804

To analyze the claims of a specific patent like 11,844,804, you need to focus on the following aspects:

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are typically broader and more comprehensive.
  • Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or features to the independent claims[4].

Claim Language and Scope

The scope of the patent is determined by the language used in the claims. Metrics such as independent claim length and independent claim count can be used to measure patent scope. Research has shown that narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Patent Subject Matter Eligibility

When evaluating the claims of a patent, it is essential to ensure they meet the subject matter eligibility criteria under Section 101 of the U.S. patent law.

Four Statutory Categories

Claims must fall within one of the four statutory categories: processes, machines, manufactures, or compositions of matter, or any improvement thereof[1].

Abstract Ideas and Natural Phenomena

Claims must not be directed to abstract ideas or natural phenomena. The Alice test is often used to determine if a claim is eligible. This involves two steps: determining if the claim is directed to an abstract idea, and if so, evaluating whether the claim includes an "inventive concept" that transforms the abstract idea into something more[1].

Patent Prosecution and Examination Process

The prosecution and examination process can significantly impact the final scope of the patent claims.

Restriction Requirements

During the examination process, the Patent and Trademark Office (PTO) may issue restriction requirements if the application includes multiple independent and distinct inventions. This was evident in the case of Hyatt v. PTO, where the applicant's claim amendments led to a restriction requirement due to the shift in the subject matter of the claims[2].

Claim Amendments and Narrowing

The examination process often results in the narrowing of patent claims. Applicants may need to amend their claims to overcome rejections, which can affect the scope and breadth of the patent protection[3].

Patent Term and URAA Implications

The term of a U.S. patent is another critical aspect, especially considering the changes brought about by the Uruguay Round Agreements Act (URAA).

URAA and Patent Term

The URAA changed the patent term from 17 years from the grant date to 20 years from the effective filing date. This change aimed to promote timely disclosure of innovations and affected transitional applications filed before the URAA took effect[2].

Reading and Interpreting Patent Claims

To fully understand the scope of a patent like 11,844,804, one must carefully read and interpret the claims.

Claim Construction

Claim construction involves interpreting the meaning of the claim language. This process is crucial in determining the scope of protection and can be a point of contention in patent litigation.

Prior Art and Field of Search

The specification and field of search sections provide context about the prior art and the classifications consulted by the patent examiner. This information helps in understanding the novelty and non-obviousness of the invention[4].

Key Takeaways

  • Claims Define Scope: The claims section is the most critical part of a patent as it legally defines the boundaries of the invention.
  • Subject Matter Eligibility: Claims must meet the criteria under Section 101 to be eligible for patent protection.
  • Prosecution and Examination: The examination process can lead to claim amendments and narrowing, affecting the patent's scope.
  • Patent Term: Understanding the patent term, especially in light of URAA, is essential for managing patent rights.
  • Claim Construction: Accurate interpretation of claim language is vital for determining the scope of protection.

FAQs

Q1: What are the four statutory categories under Section 101 of U.S. patent law? A1: The four statutory categories are processes, machines, manufactures, or compositions of matter, or any improvement thereof[1].

Q2: How does the Alice test determine patent subject matter eligibility? A2: The Alice test involves two steps: determining if the claim is directed to an abstract idea, and if so, evaluating whether the claim includes an "inventive concept" that transforms the abstract idea into something more[1].

Q3: What is the impact of the URAA on patent terms? A3: The URAA changed the patent term from 17 years from the grant date to 20 years from the effective filing date, promoting timely disclosure of innovations[2].

Q4: Why are claim amendments common during the patent examination process? A4: Claim amendments are often necessary to overcome rejections and ensure that the claims meet the criteria for patentability, which can result in the narrowing of the patent scope[3].

Q5: What is the significance of the drawings section in a U.S. patent? A5: The drawings section illustrates the technical details of the invention, helping to understand and replicate it. However, drawings are not required for all types of inventions, such as processes or methods[4].

Sources

  1. BitLaw: Patent Law in the United States - BitLaw
  2. United States Court of Appeals for the Federal Circuit: HYATT v. PTO
  3. SSRN: Patent Claims and Patent Scope
  4. Queens University Library: How to Read a U.S. Patent - Patents and Designs - Research Guides
  5. PubChem: Prefilled syringe jet injector - Patent US-8021335-B2 - PubChem

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,844,804

Showing 1 to 3 of 3 entries

International Family Members for US Patent 11,844,804

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Canada 2939791 ⤷  Try for Free
European Patent Office 3107547 ⤷  Try for Free
European Patent Office 4062918 ⤷  Try for Free
Japan 2017513809 ⤷  Try for Free
Japan 2020073545 ⤷  Try for Free
Japan 2023052550 ⤷  Try for Free
World Intellectual Property Organization (WIPO) 2015127012 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.